XML 42 R29.htm IDEA: XBRL DOCUMENT
v3.25.1

Stockholders' Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Stockholders' Equity Note [Abstract] |
Summary of Stock Option Activity | ​ A summary of the Company’s stock option activity for the Current Year is as follows:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Average | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted | ​ | Remaining | ​ | ​ | ​
​ | ​ | ​ | ​ | Average | ​ | Contractual | ​ | Aggregate
​ | ​ | Number of | ​ | Exercise | ​ | Life | ​ | Intrinsic
​ |  | Options |  | Price |  | (in Years) |  | Value
Outstanding at January 1, 2024 |  | 514,854 | ​ | $ | 20.27 |  | 4.26 | ​ | $ | —
Granted |  | 10,000 | ​ |  | 8.50 |  |  | ​ |  |
Exercised |  | — | ​ |  | — |  |  | ​ |  |
Expired/Forfeited |  | (52,462) | ​ |  | 29.35 |  |  | ​ |  |
Outstanding at December 31, 2024, and expected to vest |  | 472,392 | ​ | $ | 19.01 |  | 3.65 | ​ | $ | —
Exercisable at December 31, 2024 |  | 97,392 | ​ | $ | 27.22 |  | 1.26 | ​ | $ | —
Schedule of Black-Scholes Assumptions for Fair Value of Options Granted | The fair values of the options granted were estimated at the respective dates of grant using the Black-Scholes option pricing model with the following range of assumptions: ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended December 31, |
​ |  | 2024 |  | 2023 |
Expected Volatility |  | 78 | % | 89 – 90 | %
Expected Dividend Yield |  | — | % | — | %
Expected Life (Term, in years) |  | 3.25 |  | 2.75 – 10 | ​
Risk-Free Interest Rate |  | 4.46 | % | 4.0 – 4.7 | %
Schedule of options vesting upon achievement of target price | Of the total stock options outstanding at December 31, 2024, the vesting of 350,000 options is contingent upon the Company’s common stock achieving certain target prices as follows:
​ | ​ | ​
Target Prices |  | Number of Options Vesting
$30.00 | ​ | 100,000
$50.00 | ​ | 85,000
$70.00 | ​ | 70,000
$90.00 | ​ | 55,000
$110.00 | ​ | 40,000
​
Summary of Stock Option Activity for Non-Vested Options | The following table summarizes the Company’s stock option activity for non-vested options for the Current Year: ​
​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Weighted
​ | ​ | ​ | ​ | Average
​ | ​ | Number of | ​ | Grant Date
​ |  | Options |  | Fair Value
Balance at January 1, 2024 |  | 375,000 | ​ | $ | 0.37
Granted |  | 10,000 | ​ |  | 4.72
Vested |  | (10,000) | ​ | ​ | 9.02
Forfeited or Canceled |  | — | ​ |  | —
Balance at December 31, 2024 |  | 375,000 | ​ | $ | 0.24
​
Summary of Restricted Stock Activity | A summary of the Company’s restricted stock activity for the Current Year is as follows: ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted
​ | ​ | Number of | ​ | Average
​ | ​ | Restricted | ​ | Grant Date
​ |  | Shares |  | Fair Value
Outstanding at January 1, 2024 |  | 33,333 | ​ | $ | 36.81
Granted |  | 30,770 | ​ |  | 8.45
Vested |  | (28,770) | ​ |  | 8.94
Expired/Forfeited |  | — | ​ |  | —
Outstanding at December 31, 2024 |  | 35,333 | ​ | $ | 34.80
​
Summary of Warrant Activity | A summary of the Company’s warrant activity for the Current Year is as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Average | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted | ​ | Remaining | ​ | ​ | ​
​ | ​ | ​ |  | Average |  | Contractual | ​ | Aggregate
​ | ​ | Number of | ​ | Exercise |  | Life | ​ | Intrinsic
​ |  | Warrants |  | Price |  | (in Years) |  | Value
Outstanding and exercisable at January 1, 2024 |  | 111,606 | ​ | $ | 16.71 |  | 8.46 | ​ | $ | —
Issued |  | 163,957 | ​ |  | 6.52 |  | ​ | ​ |  |
Exercised |  | — | ​ |  | — |  | ​ | ​ |  |
Expired/Forfeited |  | (11,606) | ​ |  | 31.46 |  | ​ | ​ |  |
Outstanding at December 31, 2024 |  | 263,957 | ​ | $ | 9.73 |  | 8.96 | ​ | $ | —
Exercisable at December 31, 2024 |  | 163,957 | ​ | $ | 6.52 |  | 9.31 | ​ | $ | —
Schedule Of Common Stock Repurchased | The following table provides information with respect to restricted stock purchased and retired by the Company during the Current Year:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Number of | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Shares | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Purchased as | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Part of | ​ | ​ | ​
​ | ​ | Total Number | ​ | Actual | ​ | Publicly | ​ | Fair value of
​ | ​ | of Shares | ​ | Price Paid | ​ | Announced | ​ | Re-Purchased
Date |  | Purchased |  | per Share |  | Plan |  | Shares
July 31, 2024 (i) | ​ | 1,344 | ​ | $ | 7.20 |  | — | ​ | $ | 9,680
August 31, 2024 (i) | ​ | 2,760 | ​ | ​ | 7.03 | ​ | — | ​ | ​ | 19,411
September 30, 2024 (i) | ​ | 2,594 | ​ | ​ | 7.48 | ​ | — | ​ | ​ | 19,411
October 31, 2024(i) | ​ | 2,458 | ​ | ​ | 7.89 | ​ | — | ​ | ​ | 19,411
November 31, 2024 (i) | ​ | 2,824 | ​ | ​ | 6.87 | ​ | — | ​ | ​ | 19,411
December 31, 2024 (i) |  | 3,768 | ​ |  | 5.15 |  | — | ​ |  | 19,411
Total 2024 |  | 15,748 | ​ | $ | 6.78 |  | — | ​ | $ | 106,735
​
(i) | The shares were exchanged from employees in connection with the income tax withholding obligations on behalf of such employees from the receipt of stock awards. The 2011 Plan and 2021 Plan allow for award holders to surrender vested shares to cover withholding tax liabilities.

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in stock options. + References No definition available. + Details
Name: | us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number of common stock repurchased during the period. + References No definition available. + Details
Name: | xelb_ScheduleOfCommonStockRepurchasedTableTextBlock
Namespace Prefix: | xelb_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration